Marc Nash - Jan 12, 2024 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
By: John L Brottem For: Marc Nash
Stock symbol
OM
Transactions as of
Jan 12, 2024
Transactions value $
-$290,862
Form type
4
Date filed
1/17/2024, 08:01 PM
Previous filing
Nov 17, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Award $0 +96K +212.23% $0.00 141K Jan 12, 2024 Direct F1, F2
transaction OM Common Stock Award $0 +100K +70.8% $0.00 241K Jan 12, 2024 Direct F3
transaction OM Common Stock Award $0 +3.16K +1.31% $0.00 244K Jan 12, 2024 Direct F4
transaction OM Common Stock Sale -$291K -678 -0.28% $429.00* 244K Jan 16, 2024 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.
F2 This reflects the correct starting balance of directly owned shares which was incorrectly reported due to an administrative error in the original Form 3 filed on July 24, 2023.
F3 Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock.
F4 On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date.
F5 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (4) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.